Nelson push for faster drug development

Published



Most of the thousands of new anti-cancer medicines in development will fail clinical trials, after millions of dollars and more than 10 years are spent for testing and review.

But this approach won’t work to quickly and effectively find cancer treatments, said Dr. William Nelson, director of the Johns Hopkins Kimmel Cancer Center.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.